Patents by Inventor Allan Rettie

Allan Rettie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9074257
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Grant
    Filed: November 7, 2013
    Date of Patent: July 7, 2015
    Assignee: UNIVERSITY OF WASHINGTON
    Inventors: Mark J. Rieder, Allan Rettie
  • Publication number: 20140148505
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Application
    Filed: November 7, 2013
    Publication date: May 29, 2014
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Mark J. Rieder, Allan Rettie
  • Patent number: 8614060
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Grant
    Filed: January 18, 2011
    Date of Patent: December 24, 2013
    Assignee: University of Washington
    Inventors: Mark J. Rieder, Allan Rettie
  • Patent number: 8153366
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Grant
    Filed: March 16, 2007
    Date of Patent: April 10, 2012
    Assignee: University of Washington
    Inventors: Mark J. Rieder, Allan Rettie
  • Publication number: 20110251272
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Application
    Filed: January 18, 2011
    Publication date: October 13, 2011
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Mark J. Rieder, Allan Rettie
  • Patent number: 7888016
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Grant
    Filed: March 16, 2007
    Date of Patent: February 15, 2011
    Assignee: The University of Washington
    Inventors: Mark J. Rieder, Allan Rettie
  • Patent number: 7829282
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Grant
    Filed: March 16, 2007
    Date of Patent: November 9, 2010
    Assignee: The University of Washington
    Inventors: Mark J. Rieder, Allan Rettie
  • Publication number: 20080318219
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Application
    Filed: March 16, 2007
    Publication date: December 25, 2008
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Mark J. RIEDER, Allan RETTIE
  • Patent number: 7445896
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Grant
    Filed: October 18, 2004
    Date of Patent: November 4, 2008
    Assignee: University of Washington
    Inventors: Mark J. Rieder, Allan Rettie
  • Publication number: 20080057500
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Application
    Filed: March 16, 2007
    Publication date: March 6, 2008
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Mark RIEDER, Allan RETTIE
  • Publication number: 20080050733
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Application
    Filed: March 16, 2007
    Publication date: February 28, 2008
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Mark RIEDER, Allan RETTIE
  • Publication number: 20080050732
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Application
    Filed: March 16, 2007
    Publication date: February 28, 2008
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Mark Rieder, Allan Rettie
  • Publication number: 20060084081
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on the level of expression of the VKORC1 gene.
    Type: Application
    Filed: May 31, 2005
    Publication date: April 20, 2006
    Applicant: University of Washington
    Inventors: Mark Rieder, Allan Rettie
  • Publication number: 20060084070
    Abstract: The present invention relates to methods and compositions for predicting drug responses. In particular, the present invention provides methods and compositions for determining individualized Warfarin dosages based on genotype of DNA polymorphisms and haplotypes derived from them in the VKORC1 gene.
    Type: Application
    Filed: October 18, 2004
    Publication date: April 20, 2006
    Applicant: The University of Washington
    Inventors: Mark Rieder, Allan Rettie